A detailed history of Pnc Financial Services Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,338,647 shares of ABBV stock, worth $768 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
4,338,647
Previous 4,355,483 0.39%
Holding current value
$768 Million
Previous $747 Million 14.69%
% of portfolio
0.55%
Previous 0.5%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $2.76 Million - $3.36 Million
-16,836 Reduced 0.39%
4,338,647 $857 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $11.3 Million - $13.2 Million
-72,858 Reduced 1.65%
4,355,483 $747 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $48.3 Million - $55 Million
-301,962 Reduced 6.38%
4,428,341 $806 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $6.3 Million - $7.09 Million
-45,777 Reduced 0.96%
4,730,303 $733 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $4.95 Million - $5.73 Million
-37,045 Reduced 0.77%
4,776,080 $712 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $12.7 Million - $15.8 Million
-95,751 Reduced 1.95%
4,813,125 $648 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $4.32 Million - $4.97 Million
-29,854 Reduced 0.6%
4,908,876 $782 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $2.94 Million - $3.53 Million
-21,257 Reduced 0.43%
4,938,730 $799 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $8.89 Million - $10.2 Million
-66,266 Reduced 1.32%
4,959,987 $666 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $10.4 Million - $13.2 Million
-75,458 Reduced 1.48%
5,026,253 $770 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $10.3 Million - $12.8 Million
-77,932 Reduced 1.5%
5,101,711 $827 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $20.4 Million - $25.8 Million
190,109 Added 3.81%
5,179,643 $701 Million
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $16.6 Million - $18.8 Million
-155,912 Reduced 3.03%
4,989,534 $538 Million
Q2 2021

Aug 06, 2021

SELL
$105.21 - $117.21 $1.24 Million - $1.39 Million
-11,822 Reduced 0.23%
5,145,446 $580 Million
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $7.99 Million - $8.8 Million
-78,130 Reduced 1.49%
5,157,268 $558 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $2.72 Million - $3.67 Million
-33,787 Reduced 0.64%
5,235,398 $561 Million
Q3 2020

Nov 06, 2020

BUY
$85.91 - $100.83 $1.01 Million - $1.19 Million
11,781 Added 0.22%
5,269,185 $462 Million
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $33.5 Million - $44.9 Million
456,877 Added 9.52%
5,257,404 $516 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $45.4 Million - $68.8 Million
703,269 Added 17.16%
4,800,527 $366 Million
Q4 2019

Feb 07, 2020

SELL
$72.13 - $90.25 $881,644 - $1.1 Million
-12,223 Reduced 0.3%
4,097,258 $363 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $2.92 Million - $3.51 Million
-46,360 Reduced 1.12%
4,109,481 $311 Million
Q2 2019

Aug 09, 2019

SELL
$65.7 - $83.98 $4.91 Million - $6.28 Million
-74,806 Reduced 1.77%
4,155,841 $0
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $50.8 Million - $59.8 Million
-658,509 Reduced 13.47%
4,230,647 $0
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $5.67 Million - $6.99 Million
-72,849 Reduced 1.47%
4,889,156 $451 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $19.6 Million - $21.7 Million
-219,985 Reduced 4.25%
4,962,005 $0
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $2.75 Million - $3.25 Million
-30,622 Reduced 0.59%
5,181,990 $0
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $2.91 Million - $3.9 Million
-31,616 Reduced 0.6%
5,212,612 $0
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $40.4 Million - $44.3 Million
450,898 Added 9.41%
5,244,228 $0
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $335 Million - $428 Million
4,793,330
4,793,330 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.